longbridge

Avalyn Pharma

AVLN
----

All Shareholders

Shareholder Type

  • Institutions60.18%
  • VC/PE firms34.63%
  • Hedge funds5.19%
  • Individuals & Insiders0.00%

Major Shareholders

Major Shareholders Latest
Shareholder
Novo Holdings A/S
8.76%3.88M--+3.88M
FMR LLC
8.01%3.55M--+3.55M
T. Rowe Price Group, Inc.
7.53%3.34M--+3.34M
SR One Capital Management, LP
7.46%3.31M--+3.31M
Perceptive Advisors LLC
6.03%2.68M--+2.68M
Montanova Capital, LLC
5.65%2.50M--+2.50M
Impresa Management LLC
5.15%2.28M--+2.28M
F Prime, Inc.
5.15%2.28M--+2.28M
NVP Associates, LLC
5.12%2.27M--+2.27M
Wellington Management Group LLP
4.97%2.20M--+2.20M
Catalio Capital Management, LP
3.78%1.68M--+1.68M
Eventide Asset Management, LLC
3.10%1.38M--+1.38M
Bellevue Asset Management AG
3.05%1.35M--+1.35M
Vida Ventures Advisors, LLC
2.88%1.28M--+1.28M
BlackRock, Inc.
2.20%977.26K--+977.26K
Pivotal BioVenture Partners LLC
2.18%966.79K--+966.79K
Citadel Advisors LLC
2.16%959.10K--+959.10K
Andera Partners
2.10%929.82K--+929.82K
Vanguard Capital Management, LLC
1.93%856.53K--+856.53K
Jennison Associates LLC
1.83%812.75K--+812.75K
© 2026 Longbridge｜Terms of ServicePrivacy Policy